Krystal Biotech(KRYS)
$305.23-0.45 (-0.15%)
KRYS
Krystal Biotech hedge funds
$305.23
At close:-0.45 (-0.15%)
Want to see KRYS full AI Analyst Report?
Krystal Biotech (KRYS) Hedge Fund Trading Activity
736 Followers
Trend: ▲ Hedge Funds Increased Holdings by 238.0K Shares Last Quarter
Hedge Fund Holdings in KRYS
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
| Hussman Strategic Advisors Inc | New | 100.00% | $1,396,752 | 0.32% | |||
| Woodline Partners LP | Not Changed | 0.00% | $50,088,857 | 0.15% | |||
| S Squared Technology, LLC | Not Changed | 0.00% | $25,788,365 | 8.00% | |||
| Bridgewater Associates, LP | Not Changed | 0.00% | $18,120,862 | 0.07% | |||
| Gilder Gagnon Howe & Co LLC. | Not Changed | 0.00% | $13,400,838 | 0.14% | |||
| Clough Capital Partners L P | Not Changed | 0.00% | $3,078,508 | 0.25% | |||
| Fisher Asset Management LLC | Reduced | -2.62% | $8,963,157 | <0.01% | |||
| Reduced | -14.13% | $1,194,099,913 | 0.02% |
FAQ
Which hedge funds hold Krystal Biotech?
The hedge funds that hold the most shares in Krystal Biotech are BlackRock, Inc., Michael Rockefeller and Travis Knapp Anderson.
Are hedge funds buying or selling KRYS?
In the last quarter hedge funds have Increased their holdings in Krystal Biotech by 238.0K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Krystal Biotech stock?
Warren Buffet currently does not own shares in Krystal Biotech.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here

